You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
方盛製藥(603998.SH):與香港同盛擬對芙雅生物合計增資8000萬元 滿足其在工業大麻業務方面發展的需求
格隆匯 12-17 18:08

格隆匯12月17日丨方盛製藥(603998.SH)公佈,公司與香港同盛實業有限公司(“香港同盛”)就公司全資子公司雲南芙雅生物科技有限公司(“芙雅生物”或“目標公司”)增資事項簽署了《增資協議》;

芙雅生物此次新增註冊資本人民幣8000萬元,公司以貨幣方式增資5000萬元,香港同盛以其持有的工業大麻提取專有技術(包括該專有技術的中國內地專利申請權和專利權)經評估後作價3000萬元進行增資,新增資金8000萬元全部計入芙雅生物註冊資本。

增資擴股完成後,芙雅生物的註冊資本將由2000萬元增加至10000萬元;公司持股比例由100%降至70%。

次增資主要是為了滿足芙雅生物在工業大麻業務方面發展的需求,引進香港同盛作為芙雅生物新的股東,有利於通過合作提高芙雅生物提取技術水平,促進相關產品的研發及生產。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account